Bolivia (Plurinational State of) vs Liberia: Proportion of the target population … measles-containing-vaccine
Bolivia (Plurinational State of)
61.0%
in 2024
Liberia
60.0%
in 2024
Bolivia (Plurinational State of) rank
168th
Liberia rank
170th
Proportion of the target population … measles-containing-vaccine over time
- Bolivia (Plurinational State of)
- Liberia
How they compare
Bolivia (Plurinational State of) currently reports 61.0% against 60.0% in Liberia, a difference of 1.0%.
The two have swapped places 2 times across 6 shared years of data; in 2019 it was Bolivia (Plurinational State of) ahead.
Bolivia (Plurinational State of) ranks 168th and Liberia ranks 170th of 195 countries.
Bolivia (Plurinational State of) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia (Plurinational State of) | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.0% | 13.0% | 31.0% | Bolivia (Plurinational State of) |
| 2020s | 52.4% | 48.8% | 3.6% | Bolivia (Plurinational State of) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Bolivia (Plurinational State of) or Liberia?
- Bolivia (Plurinational State of), at 61.0% against 60.0% in Liberia as of 2024.
- What is the difference in proportion of the target population who received between Bolivia (Plurinational State of) and Liberia?
- 1.0%, with Bolivia (Plurinational State of) ahead.
- How many years of comparable data are there for Bolivia (Plurinational State of) and Liberia?
- 6 years are reported by both, from 2019 to 2024.
- How do Bolivia (Plurinational State of) and Liberia rank globally for proportion of the target population who received?
- Bolivia (Plurinational State of) ranks 168th and Liberia ranks 170th of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.